Colonial Trust Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.1M | Sell |
35,961
-694
| -2% | -$704K | 2.57% | 7 |
|
|
2025
Q4 | $39.4M | Sell |
36,655
-322
| -0.9% | -$308K | 2.96% | 6 |
|
|
2025
Q3 | $28.2M | Sell |
36,977
-349
| -0.9% | -$260K | 2.17% | 8 |
|
|
2025
Q2 | $29.1M | Buy |
37,326
+573
| +2% | +$445K | 2.4% | 7 |
|
|
2025
Q1 | $30.4M | Sell |
36,753
-63
| -0.2% | -$52.4K | 2.7% | 4 |
|
|
2024
Q4 | $28.4M | Sell |
36,816
-964
| -3% | -$798K | 2.52% | 5 |
|
|
2024
Q3 | $33.5M | Buy |
37,780
+798
| +2% | +$717K | 2.89% | 4 |
|
|
2024
Q2 | $33.5M | Sell |
36,982
-1,854
| -5% | -$1.48M | 3.21% | 3 |
|
|
2024
Q1 | $30.2M | Sell |
38,836
-817
| -2% | -$581K | 2.99% | 4 |
|
|
2023
Q4 | $23.1M | Sell |
39,653
-3,254
| -8% | -$1.9M | 2.45% | 4 |
|
|
2023
Q3 | $23M | Sell |
42,907
-3,306
| -7% | -$1.7M | 2.64% | 4 |
|
|
2023
Q2 | $21.7M | Sell |
46,213
-1,763
| -4% | -$739K | 2.41% | 4 |
|
|
2023
Q1 | $16.5M | Sell |
47,976
-1,858
| -4% | -$627K | 1.94% | 10 |
|
|
2022
Q4 | $18.2M | Sell |
49,834
-357
| -0.7% | -$127K | 2.24% | 7 |
|
|
2022
Q3 | $16.2M | Buy |
50,191
+583
| +1% | +$185K | 2.2% | 6 |
|
|
2022
Q2 | $16.1M | Sell |
49,608
-1,027
| -2% | -$308K | 2.26% | 8 |
|
|
2022
Q1 | $14.5M | Sell |
50,635
-430
| -0.8% | -$111K | 1.72% | 17 |
|
|
2021
Q4 | $14.1M | Sell |
51,065
-1,334
| -3% | -$338K | 1.58% | 20 |
|
|
2021
Q3 | $12.1M | Sell |
52,399
-490
| -0.9% | -$121K | 1.49% | 19 |
|
|
2021
Q2 | $12.1M | Sell |
52,889
-158
| -0.3% | -$31.7K | 1.48% | 19 |
|
|
2021
Q1 | $9.91M | Sell |
53,047
-1,964
| -4% | -$384K | 1.3% | 20 |
|
|
2020
Q4 | $9.29M | Buy |
55,011
+1,608
| +3% | +$240K | 1.29% | 21 |
|
|
2020
Q3 | $7.91M | Sell |
53,403
-169
| -0.3% | -$26.2K | 1.24% | 21 |
|
|
2020
Q2 | $8.79M | Buy |
53,572
+721
| +1% | +$111K | 1.5% | 18 |
|
|
2020
Q1 | $7.33M | Buy |
52,851
+1,467
| +3% | +$202K | 1.53% | 20 |
|
|
2019
Q4 | $6.75M | Sell |
51,384
-324
| -0.6% | -$37.6K | 1.12% | 32 |
|
|
2019
Q3 | $5.78M | Buy |
51,708
+797
| +2% | +$88.7K | 1.02% | 34 |
|
|
2019
Q2 | $5.64M | Buy |
50,911
+26
| +0.1% | +$3.06K | 1.02% | 33 |
|
|
2019
Q1 | $6.6M | Buy |
50,885
+5,304
| +12% | +$645K | 1.25% | 27 |
|
|
2018
Q4 | $5.28M | Sell |
45,581
-3,813
| -8% | -$426K | 1.29% | 26 |
|
|
2018
Q3 | $5.3M | Buy |
49,394
+74
| +0.2% | +$7.4K | 0.99% | 36 |
|
|
2018
Q2 | $4.21M | Buy |
49,320
+803
| +2% | +$66K | 0.83% | 40 |
|
|
2018
Q1 | $3.75M | Sell |
48,517
-16,950
| -26% | -$1.36M | 0.77% | 47 |
|
|
2017
Q4 | $5.53M | Buy |
65,467
+16,973
| +35% | +$1.44M | 0.86% | 43 |
|
|
2017
Q3 | $4.15M | Sell |
48,494
-913
| -2% | -$74.9K | 0.91% | 39 |
|
|
2017
Q2 | $4.07M | Buy |
49,407
+16,504
| +50% | +$1.35M | 0.92% | 37 |
|
|
2017
Q1 | $2.64M | Buy |
32,903
+17,066
| +108% | +$1.37M | 0.81% | 42 |
|
|
2016
Q4 | $1.17M | Buy |
15,837
+3,837
| +32% | +$286K | 0.38% | 77 |
|
|
2016
Q3 | $963K | Buy |
12,000
+65
| +0.5% | +$5.2K | 0.3% | 84 |
|
|
2016
Q2 | $940K | Sell |
11,935
-150
| -1% | -$11.3K | 0.3% | 83 |
|
|
2016
Q1 | $870K | Buy |
12,085
+610
| +5% | +$46.2K | 0.28% | 86 |
|
|
2015
Q4 | $967K | Buy |
11,475
+1,875
| +20% | +$156K | 0.32% | 81 |
|
|
2015
Q3 | $803K | Hold |
9,600
| – | – | 0.27% | 85 |
|
|
2015
Q2 | $802K | Sell |
9,600
-500
| -5% | -$38.1K | 0.25% | 92 |
|
|
2015
Q1 | $734K | Buy |
10,100
+1,625
| +19% | +$116K | 0.22% | 95 |
|
|
2014
Q4 | $585K | Sell |
8,475
-1,275
| -13% | -$86.1K | 0.23% | 92 |
|
|
2014
Q3 | $632K | Hold |
9,750
| – | – | 0.2% | 92 |
|
|
2014
Q2 | $606K | Buy |
9,750
+4,425
| +83% | +$264K | 0.18% | 96 |
|
|
2014
Q1 | $313K | Buy |
+5,325
| New | +$297K | 0.1% | 116 |
|
Other funds holding LLY
VCM
VPM
Colonial Trust Advisors's LLY Position: Q1 2026 in Review
Colonial Trust Advisors reduced its Eli Lilly (LLY) stake by 1.9% in Q1 2026, selling an estimated $704K and leaving 35,961 shares worth $33.1M. The position accounts for 2.57% of the portfolio, ranked #7.
Colonial Trust Advisors first reported a position in LLY in Q1 2014 and has held it in 49 quarters since. The position peaked at $39.4M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Colonial Trust Advisors held 35,961 shares of Eli Lilly worth $33.1M as of Q1 2026.
- Colonial Trust Advisors sold 694 Eli Lilly shares in Q1 2026, an estimated $704K.
- Eli Lilly made up 2.57% of Colonial Trust Advisors's portfolio in Q1 2026, its #7 holding.
- Colonial Trust Advisors first reported a position in Eli Lilly in Q1 2014 and has held it in 49 quarters since.
- Colonial Trust Advisors's Eli Lilly position peaked at $39.4M in Q4 2025.
- 4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Colonial Trust Advisors's 13F filing for Q1 2026, filed 12 May 2026.